Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Genome Biol ; 18(1): 92, 2017 05 17.
Article in English | MEDLINE | ID: mdl-28511701

ABSTRACT

BACKGROUND: Conditional knockout mice and transgenic mice expressing recombinases, reporters, and inducible transcriptional activators are key for many genetic studies and comprise over 90% of mouse models created. Conditional knockout mice are generated using labor-intensive methods of homologous recombination in embryonic stem cells and are available for only ~25% of all mouse genes. Transgenic mice generated by random genomic insertion approaches pose problems of unreliable expression, and thus there is a need for targeted-insertion models. Although CRISPR-based strategies were reported to create conditional and targeted-insertion alleles via one-step delivery of targeting components directly to zygotes, these strategies are quite inefficient. RESULTS: Here we describe Easi-CRISPR (Efficient additions with ssDNA inserts-CRISPR), a targeting strategy in which long single-stranded DNA donors are injected with pre-assembled crRNA + tracrRNA + Cas9 ribonucleoprotein (ctRNP) complexes into mouse zygotes. We show for over a dozen loci that Easi-CRISPR generates correctly targeted conditional and insertion alleles in 8.5-100% of the resulting live offspring. CONCLUSIONS: Easi-CRISPR solves the major problem of animal genome engineering, namely the inefficiency of targeted DNA cassette insertion. The approach is robust, succeeding for all tested loci. It is versatile, generating both conditional and targeted insertion alleles. Finally, it is highly efficient, as treating an average of only 50 zygotes is sufficient to produce a correctly targeted allele in up to 100% of live offspring. Thus, Easi-CRISPR offers a comprehensive means of building large-scale Cre-LoxP animal resources.


Subject(s)
Clustered Regularly Interspaced Short Palindromic Repeats , Gene Editing/methods , Mice, Transgenic/genetics , Mutagenesis, Insertional/methods , Ribonucleoproteins/genetics , Animals , DNA, Single-Stranded/genetics , DNA, Single-Stranded/metabolism , Endonucleases/genetics , Endonucleases/metabolism , Founder Effect , Genes, Reporter , Genetic Loci , Integrases/genetics , Integrases/metabolism , Mice , Mice, Transgenic/growth & development , Microinjections , RNA, Guide, Kinetoplastida/genetics , RNA, Guide, Kinetoplastida/metabolism , Recombinational DNA Repair , Ribonucleoproteins/metabolism , Zygote/growth & development , Zygote/metabolism
2.
Methods ; 121-122: 16-28, 2017 05 15.
Article in English | MEDLINE | ID: mdl-28351759

ABSTRACT

Genome editing using the CRISPR/Cas9 system requires the presence of guide RNAs bound to the Cas9 endonuclease as a ribonucleoprotein (RNP) complex in cells, which cleaves the host cell genome at sites specified by the guide RNAs. New genetic material may be introduced during repair of the double-stranded break via homology dependent repair (HDR) if suitable DNA templates are delivered with the CRISPR components. Early methods used plasmid or viral vectors to make these components in the host cell, however newer approaches using recombinant Cas9 protein with synthetic guide RNAs introduced directly as an RNP complex into cells shows faster onset of action with fewer off-target effects. This approach also enables use of chemically modified synthetic guide RNAs that have improved nuclease stability and reduces the risk of triggering an innate immune response in the host cell. This article provides detailed methods for genome editing using the RNP approach with synthetic guide RNAs using lipofection or electroporation in mammalian cells or using microinjection in murine zygotes, with or without addition of a single-stranded HDR template DNA.


Subject(s)
Bacterial Proteins/genetics , CRISPR-Cas Systems , Endonucleases/genetics , Gene Editing/methods , Gene Transfer Techniques , RNA, Guide, Kinetoplastida/genetics , Ribonucleoproteins/genetics , Animals , Bacterial Proteins/metabolism , Base Sequence , CRISPR-Associated Protein 9 , Clustered Regularly Interspaced Short Palindromic Repeats , DNA/genetics , DNA/metabolism , Electroporation , Endonucleases/metabolism , Gene Targeting/methods , Genome , HEK293 Cells , Humans , Jurkat Cells , Lipids/chemistry , Mice , Microinjections , RNA, Guide, Kinetoplastida/chemical synthesis , RNA, Guide, Kinetoplastida/metabolism , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Recombinational DNA Repair , Ribonucleoproteins/metabolism , Zygote/cytology , Zygote/metabolism
3.
Infect Immun ; 81(12): 4453-60, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24042120

ABSTRACT

The production of type 1 fimbriae in Salmonella enterica serovar Typhimurium is controlled, in part, by three proteins, FimZ, FimY, and FimW. Amino acid sequence analysis indicates that FimZ belongs to the family of bacterial response regulators of two-component systems. In these studies, we have demonstrated that introducing a mutation mimicking phosphorylation of FimZ is necessary for activation of its target gene, fimA. In addition, the interaction of FimZ with FimW, a repressor of fimA expression, occurs only when FimZ is phosphorylated. Consequently, the negative regulatory effect of FimW is most likely due to downmodulation of the active FimZ protein. FimY does not appear to function as a response regulator, and its activity can be lost by mimicking the phosphorylation of FimY. Overproduction of FimY cannot alleviate the nonfimbriate phenotype in a FimZ mutant, whereas high levels of FimZ can overcome the nonfimbriate phenotype of a FimY mutant. It appears that FimY acts upstream of FimZ to activate fimA expression.


Subject(s)
Antigens, Bacterial/metabolism , Bacterial Proteins/metabolism , DNA-Binding Proteins/metabolism , Fimbriae Proteins/metabolism , Fimbriae, Bacterial/metabolism , Amino Acid Sequence , Antigens, Bacterial/biosynthesis , Fimbriae Proteins/biosynthesis , Fimbriae, Bacterial/genetics , Gene Expression Regulation, Bacterial , Phosphorylation , Salmonella typhimurium/genetics , Salmonella typhimurium/metabolism , Sequence Analysis, Protein
4.
Infect Immun ; 80(9): 3289-96, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22778099

ABSTRACT

Salmonella enterica serovar Typhimurium is a Gram-negative member of the family Enterobacteriaceae and is a common cause of bacterial food poisoning in humans. The fimbrial appendages are found on the surface of many enteric bacteria and enable the bacteria to bind to eukaryotic cells. S. Typhimurium type 1 fimbriae are characterized by mannose-sensitive hemagglutination and are assembled via the chaperone/usher pathway. S. Typhimurium type 1 fimbrial proteins are encoded by the fim gene cluster (fimAICDHFZYW), with fimAICDHF expressed as a single transcriptional unit. The structural components of the fimbriae are FimA (major subunit), FimI, FimH (adhesin), and FimF (adaptor). In order to determine which components are required for fimbrial formation in S. Typhimurium, mutations in fimA, fimI, fimH, and fimF were constructed and examined for their ability to produce surface-assembled fimbriae. S. Typhimurium SL1344ΔfimA, -ΔfimH, and -ΔfimF mutants were unable to assemble fimbriae, indicating that these genes are necessary for fimbrial production in S. Typhimurium. However, SL1344ΔfimI was able to assemble fimbriae. In Escherichia coli type 1 and Pap fimbriae, at least two adaptors are expressed in addition to the adhesins. However, E. coli type 1 and Pap fimbriae have been reported to be able to assemble fimbriae in the absence of these proteins. These results suggest differences between the S. Typhimurium type 1 fimbrial system and the E. coli type 1 and Pap fimbrial systems.


Subject(s)
Fimbriae Proteins/genetics , Fimbriae Proteins/metabolism , Fimbriae, Bacterial/metabolism , Macromolecular Substances/metabolism , Protein Multimerization , Salmonella typhimurium/physiology , Gene Deletion , Genes, Bacterial , Multigene Family , Salmonella typhimurium/genetics , Salmonella typhimurium/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...